La Jolla Pharmaceutical Company (LJPC) To Provide Corporate Overview At The 2014 Wedbush Securities Life Sciences Conference
8/11/2014 8:22:20 AM
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced that George Tidmarsh, M.D., Ph.D., President and Chief Executive Officer, will provide a corporate overview at the 2014 Wedbush Securities Life Sciences Conference taking place August 12-13 in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by